Also from this source

You just read:

PharmaEssentia Announces Favorable Two-year Results of Ropeginterferon Alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2017

News provided by

PharmaEssentia

Dec 10, 2017, 07:00 EST